IVAWe are retracing to the 200 Ma which also happens to be the 1.272 fib. this offers a short opportunity of 8.57%.
Nothing I say is financial advice.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−2.065 EUR
−110.43 M EUR
17.48 M EUR
61.31 M
About INVENTIVA
Sector
Industry
CEO
Frédéric Cren
Website
Headquarters
Daix
Founded
2011
ISIN
FR0013233012
FIGI
BBG00DGY8YM2
Inventiva SA is a clinical-stage biopharmaceutical company, which focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis, or NASH, and other diseases with significant unmet medical need. It owns an in-house drug-discovery platform that develops internal oncology and fibrosis discovery pipeline with approaches centered on transcription factors, epigenetics targets, and nuclear receptors. The company was founded by Pierre Broqua and Frédéric Cren on October 27, 2011 and is headquartered in Daix, France.
Possibility of strong rise, but beware of speculatorsThis increase of more than 30% of November 1 is not obtained as a result of news concerning Inventiva, caution, therefore, following the speculators who can in the short term vary the action.
In the long run, I think it's a big possibility if the products work and the tests succeed one after the ot
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of IVA is 2.420 EUR — it has decreased by −1.41% in the past 24 hours. Watch INVENTIVA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on EURONEXT exchange INVENTIVA stocks are traded under the ticker IVA.
IVA stock hasn't changed in a week, the month change is a 50.12% rise, over the last year INVENTIVA has showed a −36.32% decrease.
We've gathered analysts' opinions on INVENTIVA future price: according to them, IVA price has a max estimate of 14.00 EUR and a min estimate of 4.40 EUR. Watch IVA chart and read a more detailed INVENTIVA stock forecast: see what analysts think of INVENTIVA and suggest that you do with its stocks.
IVA stock is 5.11% volatile and has beta coefficient of 0.89. Track INVENTIVA stock price on the chart and check out the list of the most volatile stocks — is INVENTIVA there?
Today INVENTIVA has the market capitalization of 212.91 M, it has increased by 2.86% over the last week.
Yes, you can track INVENTIVA financials in yearly and quarterly reports right on TradingView.
INVENTIVA is going to release the next earnings report on Mar 26, 2025. Keep track of upcoming events with our Earnings Calendar.
IVA earnings for the last half-year are −0.94 EUR per share, whereas the estimation was −1.22 EUR, resulting in a 22.95% surprise. The estimated earnings for the next half-year are −0.91 EUR per share. See more details about INVENTIVA earnings.
INVENTIVA revenue for the last half-year amounts to 41.00 K EUR, despite the estimated figure of 0.00 EUR. In the next half-year revenue is expected to reach 1.88 M EUR.
IVA net income for the last half-year is −49.03 M EUR, while the previous report showed −55.16 M EUR of net income which accounts for 11.11% change. Track more INVENTIVA financial stats to get the full picture.
No, IVA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 5, 2024, the company has 123.00 employees. See our rating of the largest employees — is INVENTIVA on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. INVENTIVA EBITDA is −101.28 M EUR, and current EBITDA margin is −603.54%. See more stats in INVENTIVA financial statements.
Like other stocks, IVA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade INVENTIVA stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So INVENTIVA technincal analysis shows the neutral today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating INVENTIVA stock shows the sell signal. See more of INVENTIVA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.